Lymphocyte_NN
glucocorticoid_NN
receptor_NN
number_NN
in_IN
posttraumatic_JJ
stress_NN
disorder_NN
._.

OBJECTIVE_NN
:_:
The_DT
authors_NNS
'_POS
objective_NN
was_VBD
to_TO
investigate_VB
the_DT
possibility_NN
that_IN
glucocorticoid_NN
receptor_NN
changes_NNS
may_MD
be_VB
involved_VBN
in_IN
the_DT
dysregulation_NN
of_IN
the_DT
hypothalamic-pituitary-adrenal_JJ
-LRB-_-LRB-
HPA_NN
-RRB-_-RRB-
axis_NN
in_IN
posttraumatic_JJ
stress_NN
disorder_NN
-LRB-_-LRB-
PTSD_NN
-RRB-_-RRB-
._.

METHOD_NN
:_:
They_PRP
measured_VBD
the_DT
number_NN
of_IN
lymphocyte_NN
cytosolic_JJ
glucocorticoid_NN
receptors_NNS
and_CC
plasma_NN
cortisol_NN
concentrations_NNS
in_IN
15_CD
consecutively_RB
admitted_VBN
male_JJ
combat_NN
Vietnam_NN
veterans_NNS
with_IN
PTSD_NN
and_CC
in_IN
a_DT
normal_JJ
comparison_NN
group_NN
of_IN
11_CD
subjects_NNS
._.

RESULTS_NNS
:_:
Both_CC
the_DT
patients_NNS
and_CC
the_DT
normal_JJ
comparison_NN
subjects_NNS
showed_VBD
a_DT
morning-to-afternoon_JJ
decline_NN
in_IN
glucocorticoid_NN
receptor_NN
concentrations_NNS
,_,
paralleling_VBG
the_DT
normal_JJ
diurnal_JJ
decline_NN
in_IN
cortisol_NN
levels_NNS
._.

The_DT
number_NN
of_IN
glucocorticoid_NN
receptors_NNS
was_VBD
63_CD
%_NN
greater_JJR
in_IN
the_DT
morning_NN
and_CC
26_CD
%_NN
greater_JJR
in_IN
the_DT
afternoon_NN
in_IN
the_DT
patients_NNS
with_IN
PTSD_NN
than_IN
in_IN
the_DT
normal_JJ
subjects_NNS
._.

No_DT
group_NN
differences_NNS
in_IN
cortisol_NN
levels_NNS
were_VBD
observed_VBN
,_,
nor_CC
were_VBD
glucocorticoid_NN
receptor_NN
number_NN
and_CC
cortisol_NN
levels_NNS
correlated_VBD
._.

The_DT
number_NN
of_IN
morning_NN
glucocorticoid_NN
receptors_NNS
was_VBD
positively_RB
correlated_VBN
with_IN
symptoms_NNS
of_IN
PTSD_NN
and_CC
anxiety_NN
._.

CONCLUSIONS_NNS
:_:
These_DT
results_NNS
provide_VBP
further_JJ
evidence_NN
for_IN
a_DT
dysregulation_NN
of_IN
the_DT
HPA_JJ
axis_NN
in_IN
PTSD_NN
._.

The_DT
finding_NN
that_IN
patients_NNS
with_IN
PTSD_NN
had_VBD
a_DT
substantially_RB
greater_JJR
number_NN
of_IN
lymphocyte_NN
glucocorticoid_NN
receptors_NNS
than_IN
normal_JJ
comparison_NN
subjects_NNS
is_VBZ
consistent_JJ
with_IN
the_DT
authors_NNS
'_POS
previous_JJ
observations_NNS
of_IN
low_JJ
24-hour_JJ
urinary_JJ
cortisol_NN
excretion_NN
in_IN
subjects_NNS
with_IN
PTSD_NN
._.

Furthermore_RB
,_,
the_DT
receptor_NN
changes_NNS
observed_VBN
are_VBP
opposite_JJ
of_IN
those_DT
reported_VBN
in_IN
major_JJ
depressive_JJ
disorder_NN
._.

The_DT
present_JJ
data_NNS
,_,
along_IN
with_IN
other_JJ
findings_NNS
of_IN
HPA_JJ
abnormalities_NNS
in_IN
PTSD_NN
,_,
support_VBP
the_DT
possibility_NN
of_IN
a_DT
greater_JJR
negative_JJ
feedback_NN
sensitivity_NN
at_IN
one_CD
or_CC
more_JJR
levels_NNS
of_IN
the_DT
HPA_JJ
axis_NN
._.

